J&J raises its 2021 revenue estimates and forecast it would sell $2.5B worth of its Covid vaccines this year
The J&J vaccine, once touted as an important tool for vaccinations in hard-to-reach areas, has the least uptake in Europe among all the vaccines approved for use, and has also struggled in the United States.
J&J raised its expectations for full-year sales, encouraged by a recovery in sales at its medical devices unit and higher demand for treatments such as psoriasis and Crohn's disease drug Stelara.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bigsound 2021 Conference and Music Festival Is Canceled Due to COVID-19The 2021 edition of Australia’s Bigsound conference and showcase event has been canceled due to the lockdown measures currently in place across the country.
Read more »
Introducing Team USA's Tokyo 2021 Flag Bearers: Olympians Sue Bird and Eddy AlvarezThe 2021 Olympics flag bearers for Team USA are Sue Bird and Eddy Alvarez. The Opening Ceremony takes place on July 23.
Read more »
11 newest healthcare unicorns of 2021Business Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Read more »
Best Visa Credit Cards Of August 2021Identifying the best Visa credit card is impossible, but that didn’t stop us from trying. We’ve analyzed hundreds to bring you the 10 best Visa credit cards.
Read more »
The best 2-row and 3-row midsize luxury SUVs in 2021If you're looking for a plush and roomy SUV, these are your best bets.
Read more »
The Highest-Paid Olympians Of 2021: Going For The GoldAmong the thousands of mostly cash-strapped athletes heading to Tokyo are professionals like Djokovic, Durant and Osaka, who are some of sports’ top earners.
Read more »